Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -79.50% | -79.50% | 246.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -79.50% | -79.50% | 246.57% |
| Cost of Revenue | -- | -- | -83.38% | -83.31% | 156.97% |
| Gross Profit | -- | -- | -69.62% | -69.80% | 38.94% |
| SG&A Expenses | -- | -- | -60.05% | -60.28% | 216.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -90.53% | -90.53% | 71.56% |
| Total Operating Expenses | -- | -- | -78.16% | -78.16% | 207.43% |
| Operating Income | -- | -- | -98.46% | -98.46% | -68.31% |
| Income Before Tax | -- | -- | -220.54% | -220.54% | -155.17% |
| Income Tax Expenses | -- | -- | -463.85% | -463.87% | -292.96% |
| Earnings from Continuing Operations | -- | -- | -208.67% | -208.67% | -146.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 48.70% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -174.97% | -174.97% | -120.74% |
| EBIT | -- | -- | -98.46% | -98.46% | -68.31% |
| EBITDA | -- | -- | -93.41% | -93.43% | -83.07% |
| EPS Basic | -- | -- | -169.39% | -169.39% | -116.47% |
| Normalized Basic EPS | -- | -- | -250.17% | -250.17% | -163.20% |
| EPS Diluted | -- | -- | -168.64% | -168.64% | -114.44% |
| Normalized Diluted EPS | -- | -- | -250.17% | -250.17% | -163.20% |
| Average Basic Shares Outstanding | -- | -- | 5.24% | 5.24% | 3.52% |
| Average Diluted Shares Outstanding | -- | -- | 5.24% | 5.24% | 3.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -1.02% |